Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Clinical outcomes of patients under general anesthesia with closed-loop TIVA technique and SEDLineTM monitoring by institution

From: Technical and clinical evaluation of a closed loop TIVA system with SEDLineTM spectral density monitoring: Multicentric prospective cohort study

Care centerInstitution 1: IPS Universitaria. Medellín (n = 47)Institution 2: Hospital San José. Bogotá (n = 27)Institution 3: S.E.S Hospital de Caldas (n = 19)Consolidated Global (n = 93)
Percentage of time spent by the PSITM between 20 and 50*96 (89–99)84.8 (70.8–94)85.6 (78–96.6)92%
Episodes of hemodynamic instability**2 (4.1%)6 (22.2%)0 (0)8 (8.4%)
Need for vasopressors**1 (2%)6 (22.2%)0 (0)7 (7.4%)
Episodes of intraoperative movement**9 (18.4%)2 (7.4%)0 (0)11 (11.6%)
Surgical complications**0 (0)0 (0)0 (0)0 (0)
Adverse events**0 (0)0(0)0 (0)2 (2.1%)
Extubation time (minutes)*8 (5.5–13)11 (9–13)6 (5–8)8 (6–13)
Need for open-loop change**3 (6.1%)0 (0%)0 (0)4 (4.2%)
Need for change to halogenated anesthetics**3 (6.1%)1 (3.7%)0 (0)4 (4.2%)
PACU discharge time (minutes)*80 (60–100)100 (44–926)60 (45–120)80 (60–100)
Episodes of postoperative nausea and vomiting0 (0)0 (0)0 (0)0 (0)
Recall of intraoperative events**1(2.1%)0 (0)0 (0)1(1.1%)
Amount of propofol (mcg/kg/min)*5.84 (4.6–6.2)6.05 (5.4–7.3)5-48 (4.3–5.9)5.84 (4.6–6.2)
Amount of remifentanil (mcg/Kg/min)*9.7 (5.5–10.8)11.78 (8.6–12.8)8.4 (4.1–9.3)9.7 (5.5–10.8)
  1. *Non-normal quantitative variables. Median data (interquartile range 25–75) **Qualitative variables. Frequency data (percentage %). NA Data not available